POH18 Dilemmas and Debates in Derm
DESCRIPTION
As dermatology continues to evolve, so do the ethical challenges surrounding how we select, train, and evaluate the next generation of dermatologists. This interactive session will explore pressing ethical issues in medical student and resident education, focusing on fairness, professionalism, and accountability. Topics will include the implications of Step 1 and Step 2 pass/fail scoring, equity and merit in the residency selection process, managing learner errors, the ethics of recommendation letters and ranking systems, and the growing influence of social media in applicant evaluation. Attendees will gain practical tools for navigating ethically complex situations in education and mentorship.
LEARNING OBJECTIVES
Identify ethical dilemmas that practicing dermatologists in 2025 encounter on a regular basis.
Using ethical frameworks, outline arguments for and against the ways to address these dilemmas.
Apply techniques by which dermatologists can navigate ethical dilemmas in their daily practice.
DIRECTOR
Cheryl M. Burgess, MD, FAAD
DISCLOSURES
Cheryl M. Burgess, MD, FAAD
Aerolase – Investigator(Equipment); Allergan, Inc. – Investigator(Grants/Research Funding), Stockholder(Stock); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Merz Aesthetics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Prollenium – Investigator(Grants/Research Funding); Revance Therapeutics, Inc. – Investigator(Grants/Research Funding); Target Cool – Advisory Board(Equipment); TEOXANE Laboratories – Investigator(Grants/Research Funding);